Total Funding
70
72
Total FundingPost-IPO Debt raised
Growth Score
-20 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
26629
Amphastar Pharmaceuticals specialty pharmaceutical company that is engaged in the development, manufacture and marketing of generic.
Jack Zhang: CEO,CSO, and Director
Mary Z. Luo: Founder, COO & Chief Scientist
About the Company
Amphastar Pharmaceuticals, Inc., headquartered in Rancho Cucamonga, California, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cGMP compliant facilities to develop, manufacture, and market injectable and inhalation products.
In addition to the Corporate Headquarters, Amphastar has five
manufacturing facilities located in the United States, China and Europe along with a state-of-the-art New Drug Research Center.
Amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry.
Women Founded
